We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
DFIM
1651
Detwiler Fenton Investment Management
Massachusetts
$443K +$455K +14,456 New
RCM
1652
Rotella Capital Management
Washington
$441K -$1.1M -34,849 -71%
LCM
1653
Lucas Capital Management
New Jersey
$441K -$31.3K -995 -6%
SAMC
1654
Spectrum Asset Management (California)
California
$440K
RC
1655
Reik & Co
New York
$439K +$4.31K +137 +1%
FI
1656
FormulaFolio Investments
Michigan
$438K +$7.08K +225 +2%
TC
1657
Trust Company
Kansas
$436K -$133K -4,214 -23%
EAM
1658
Evanson Asset Management
California
$434K -$55.5K -1,763 -11%
MMPW
1659
Mitchell McLeod Pugh & Williams
Alabama
$434K +$29.8K +948 +7%
FWM
1660
Focused Wealth Management
New York
$433K +$12.5K +398 +3%
CGL
1661
Clarius Group LLC
Washington
$431K +$443K +14,087 New
FBA
1662
Front Barnett Associates
Illinois
$430K
HFA
1663
High Falls Advisors
New York
$430K +$442K +14,040 New
FA
1664
FCG Advisors
New Jersey
$424K -$9.75K -310 -2%
CHA
1665
Cedar Hill Associates
Illinois
$424K -$1.1K -35 -0.3%
Fuller & Thaler Asset Management
1666
Fuller & Thaler Asset Management
California
$423K
CISOA
1667
Capital Investment Services of America
Wisconsin
$422K
CP
1668
Coho Partners
Pennsylvania
$421K
BOS
1669
Bingham Osborn & Scarborough
California
$417K -$13.2K -419 -3%
AWP
1670
Ascent Wealth Partners
New York
$417K
TCM
1671
Texan Capital Management
Texas
$417K +$34.5K +1,096 +9%
CBB
1672
Citizens Business Bank
California
$412K +$103K +3,275 +32%
ANB
1673
Amarillo National Bank
Texas
$411K -$486K -15,435 -53%
HCM
1674
Hengehold Capital Management
Ohio
$411K +$19.9K +632 +5%
CCM
1675
Coldstream Capital Management
Washington
$409K -$3.71K -118 -0.9%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.